Exelixis Inc (EXEL)
34.83
+0.18
(+0.52%)
USD |
NASDAQ |
Nov 21, 16:00
34.82
0.00 (0.00%)
After-Hours: 20:00
Exelixis 1 Year Total Returns (Daily): 64.14% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 64.14% |
November 20, 2024 | 65.55% |
November 19, 2024 | 62.85% |
November 18, 2024 | 63.37% |
November 15, 2024 | 62.27% |
November 14, 2024 | 64.02% |
November 13, 2024 | 68.05% |
November 12, 2024 | 70.71% |
November 11, 2024 | 72.33% |
November 08, 2024 | 74.78% |
November 07, 2024 | 69.59% |
November 06, 2024 | 70.39% |
November 05, 2024 | 65.57% |
November 04, 2024 | 63.29% |
November 01, 2024 | 62.32% |
October 31, 2024 | 61.24% |
October 30, 2024 | 60.28% |
October 29, 2024 | 42.23% |
October 28, 2024 | 41.09% |
October 25, 2024 | 40.19% |
October 24, 2024 | 43.35% |
October 23, 2024 | 47.12% |
October 22, 2024 | 36.57% |
October 21, 2024 | 35.76% |
October 18, 2024 | 35.36% |
Date | Value |
---|---|
October 17, 2024 | 33.43% |
October 16, 2024 | 36.07% |
October 15, 2024 | 33.43% |
October 14, 2024 | 22.85% |
October 11, 2024 | 22.00% |
October 10, 2024 | 18.97% |
October 09, 2024 | 18.33% |
October 08, 2024 | 14.27% |
October 07, 2024 | 18.41% |
October 04, 2024 | 22.52% |
October 03, 2024 | 19.93% |
October 02, 2024 | 19.26% |
October 01, 2024 | 20.37% |
September 30, 2024 | 18.76% |
September 27, 2024 | 16.99% |
September 26, 2024 | 20.64% |
September 25, 2024 | 19.38% |
September 24, 2024 | 22.35% |
September 23, 2024 | 22.72% |
September 20, 2024 | 22.83% |
September 19, 2024 | 25.26% |
September 18, 2024 | 25.62% |
September 17, 2024 | 26.55% |
September 16, 2024 | 25.95% |
September 13, 2024 | 19.40% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-41.05%
Minimum
Mar 16 2020
74.78%
Maximum
Nov 08 2024
5.55%
Average
4.02%
Median
1 Year Total Returns (Daily) Benchmarks
Merck & Co Inc | 0.29% |
ADMA Biologics Inc | 440.6% |
Vericel Corp | 58.05% |
Catalyst Pharmaceuticals Inc | 53.71% |
Inovio Pharmaceuticals Inc | -19.10% |